Skip to content

Clinical research on a new domestic CO2 fractional laser system

Clinical research on a new domestic CO2 fractional laser system

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106299
Enrollment
Unknown
Registered
2025-07-22
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scar

Interventions

Normal skin group:Short pulse width + Low energy
Normal skin group:Short pulse width + Medium energy
Normal skin group:Short pulse width + High energy
Normal skin group:Medium pulse width + Low energy
Normal skin group:Medium pulse width + Medium energy
Normal skin group:Medium pulse width + High energy
Normal skin group:Long pulse width + Low energy
Normal skin group:Long pulse width + Medium energy
Normal skin group:Long pulse width + High energy
Scar group:Short pulse width + Low energy
Scar group:Short pulse width + Medium energy
Scar group:Short pulse width + High energy
Scar group:Medium pulse width + Low energy
Scar group:Medium pulse width + Medium energy
Scar group:Medium pulse width + High energy
Scar group:Long pulse width + Low energy
Scar group:Long pulse width + Medium energy
Scar group:Long pulse width + High energy

Sponsors

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1.Adults aged 18 to 55; 2.Without chronic underlying diseases such as diabetes and hypertension; 3.The surgical treatment area has not undergone surgery, laser treatment, radiation or chemotherapy; 4.No tissue infection or congenital malformation in the surgical area.

Exclusion criteria

Exclusion criteria: 1.History of keloid; 2.History of using isotretinoin and oral anticoagulants; 3.Suffering from chronic underlying diseases; 4.Being pregnant 5.Patients with inflammation or infection in the surgical area due to skin or tissue infection; 6.Having undergone surgery, laser, radiation or chemical drug treatment in the surgical area, or having congenital malformations.

Design outcomes

Primary

MeasureTime frame
Depth of the gasification zone;Aperture of the gasification zone;Thickness of thermal coagulation zone;

Countries

China

Contacts

Public ContactKaiyang Lv

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

lvkaiyang@hotmail.com+86 138 1698 3691

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026